Won-Jung Koh: h-index, Total Citations, and Citation Map
Won-Jung Koh's h-index is 83 (350 i10-index, 25,582+ total citations across 578+ publications) according to Google Scholar as of June 2026. Won-Jung Koh is affiliated with Samsung Medical Center.
Won-Jung Koh is a researcher affiliated with Samsung Medical Center, specializing in tuberculosis, nontuberculous mycobacteria. Their work has been cited 25,582 times. This profile visualizes their global influence, spanning a global audience.
Won-Jung Koh's Citation Metrics
Bibliometric impact based on 578 indexed publications. Of these, 4 are original research articles — the rest are literature highlights, conference abstracts or theses.
- H-Index
- 83
- i10-Index
- 350
- Total Citations
- 25,582
- Citing Countries
- 0
As of June 2026.
Won-Jung Koh has an h-index of 83 and 25,582 total citations across 578 publications, with research cited by institutions in 0 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Won-Jung Koh's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
We've mapped 5,000 of 25,582 citations for Won-Jung Koh
We've shown the most-cited 5,000. Unlock the full crawl (25,532 more citations) to see every institution citing this scholar.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Delamanid for multidrug-resistant pulmonary tuberculosis
20121,031
Top Citing Countries
Top Citing Institutions
No institution data available.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
About Won-Jung Koh's research
Won-Jung Koh is a researcher in tuberculosis and nontuberculous mycobacteria at Samsung Medical Center. Their work has been cited 25,582 times across 578 publications (h-index 83), according to Google Scholar.
Their most-cited work, “Delamanid for multidrug-resistant pulmonary tuberculosis” (2012), has accumulated 1,031 citations. Other influential works include “Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients” (2012) with 778 citations and “Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis” (2018) with 686 citations.
